ArticleLeukemia & lymphoma2023

Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies.

Audrey L Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.